Clariane SE (LON:0OPS)
5.20
-0.05 (-0.93%)
At close: Jul 8, 2025
Clariane SE Revenue
In the year 2024, Clariane SE had annual revenue of 5.28B EUR with 5.73% growth. Clariane SE had revenue of 2.65B in the half year ending December 31, 2024, with 16.31% growth.
Revenue
5.28B EUR
Revenue Growth
+5.73%
P/S Ratio
0.38
Revenue / Employee
85.47K EUR
Employees
61,798
Market Cap
1.64B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5.28B | 286.17M | 5.73% |
Dec 31, 2023 | 5.00B | 557.29M | 12.56% |
Dec 31, 2022 | 4.44B | 300.99M | 7.27% |
Dec 31, 2021 | 4.14B | 364.40M | 9.66% |
Dec 31, 2020 | 3.77B | 160.41M | 4.44% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |